Zydus Pharmaceuticals (USA) Inc: Drug Recall
Recall #D-0617-2024 · 06/21/2024
Class II: Risk
Recall Details
- Recall Number
- D-0617-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Zydus Pharmaceuticals (USA) Inc
- Status
- Terminated
- Date Initiated
- 06/21/2024
- Location
- Pennington, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 13,128 bottles; b) 252 bottles
Reason for Recall
Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.
Product Description
Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count bottles (NDC 68382-034-16) and b)1000-count bottles (NDC 68382-034-10), Rx only, Mfg. by: Zydus Lifesciences Ltd. Ahmedabad, India; Dist. by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534
Distribution Pattern
Nationwide within the United States
Other Recalls by Zydus Pharmaceuticals (USA) Inc
- Class II: Risk 12/30/2025
- Class III: Low Risk 12/19/2025
- Class II: Risk 10/23/2025
- Class II: Risk 10/22/2025
- Class II: Risk 10/22/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.